We asked our colleague Hannah Norman, Senior Project Leader in Market Access & HTA to share her experience.
💡What do project Leaders in Nordic Market Access and HTA actually do? “We help pharmaceutical companies bring life-saving and innovative medicines to market. […]
In Finland, market access for hospital drugs and medical technologies isn’t just about regulatory approval, it’s about PALKO.
The Finnish Council for Choices in Health Care (Palveluvalikoimaneuvosto, PALKO) acts as a critical gatekeeper […]
Quantify Research has co-authored a new paper on the health care and productivity costs of narcolepsy, using comprehensive Swedish registry data.
The study matched incident narcolepsy patients to controls by age and sex to […]
In pharmacovigilance, high-quality data isn’t just about meeting regulatory checkboxes, it’s a vital cornerstone in protecting patient safety.
When pharmacovigilance falls short, the repercussions can be severe, from misleading safety statistics to, in the worst cases, preventable harm or even death. […]
Yesterday, Quantify Research was invited to a hearing to present on the topic of managed entry agreement […]
We are:
a team of 6️⃣0️⃣ thinkers, doers, and innovators
speaking 1️⃣5️⃣ languages,
representing 1️⃣2️⃣ nationalities,
located in 0️⃣7️⃣ countries
We bridge local and global perspectives in everything we do.
Our new home in the athagoras Group extends this […]
Quantify Research is an experienced market access partner for global HQs and local reimbursement across the Nordics, not least in Denmark.
One highlight is our collaboration with Niels Christian Hirsch, a Senior Advisor to […]
Findata – Finnish Social and Health Data Permit Authority has published its annual review of 2024. Here are some highlights:
🟢 In 2024, Findata turned 5 […]
Here are some of the things that makes our data unique:
1️⃣Fast access to comprehensive data
The average time to fully process applications at The Danish Health Data Authority ( […]
Certain patient groups may be underrepresented or excluded from RCTs due to eligibility criteria, logistical barriers, ethical concerns or other reasons.
Examples of these potential groups are females, pregnant or breastfeeding females, older adults due to age or comorbidities, children, people […]